Association of serum retinol-binding protein 4 with insulin resistance and metabolic parameters during olanzapine therapy

Clinical Endocrinology

Volumn 76, Issue 2, 2012, Pages 207-211

  Faghihi, Toktam ^a   Radfar, Mania ^a   Abdoli, Elahe ^a   Amini, Homayoun ^b   Rezaei Hemami, Mohsen ^c   Larijani, Bagher ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; LORAZEPAM; LOW DENSITY LIPOPROTEIN; OLANZAPINE; RETINOL BINDING PROTEIN 4;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; INSULIN RESISTANCE; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84855417107     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04150.x     Document Type: Article

References (27)

1. Pramyothin, P., &, Khaodhiar, L., (2010) Metabolic syndrome with the atypical antipsychotics. Current Opinion in Endocrinology, Diabetes and Obesity, 17, 460-466.
2. Tschoner, A., Engl, J., Laimer, M., et al. (2007) Metabolic side effects of antipsychotic medication. International Journal of Clinical Practice, 61, 1356-1370. (Pubitemid 47052363)
3. Newcomer, J.W., (2007) Antipsychotic medications: metabolic and cardiovascular risk. The Journal of Clinical Psychiatry, 68, 8-13. (Pubitemid 46762118)
4. Newcomer, J.W., (2005) Second generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs, 19, 1-93. (Pubitemid 40677047)
5. Newcomer, J.W., &, Hennekens, C.H., (2007) Severe mental illness and risk of cardiovascular disease. JAMA, 298, 1794-1796. (Pubitemid 47598448)
6. Rasouli, N., &, Kern, P.A., (2008) Adipocytokines and the metabolic complications of obesity. Journal of Clinical Endocrinology and Metabolism, 93, s64-s73.
7. Rabe, K., Lehrke, M., Parhofer, K.G., et al. (2008) Adipokines and insulin resistance. Molecular Medicine, 14, 741-751.
8. Ulgen, F., Herder, C., Kuhn, M.C., et al. (2010) Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients. Archives of Physiology and Biochemistry, 116, 57-62.
9. Graham, T.E., Yang, Q., Bluher, M., et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New England Journal of Medicine, 354, 2552-2562.
10. Gavi, S., Stuart, L.M., Kelly, P., et al. (2007) Retinol binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. Journal of Clinical Endocrinology and Metabolism, 92, 1886-1890. (Pubitemid 46997205)
11. Qibin, Qi., Zhijie, Yu., Xingwang, Ye., et al. (2007) Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. Journal of Clinical Endocrinology and Metabolism, 92, 4827-4834.
12. Lee, D.C., Lee, J.W., &, Im, J.A., (2007) Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism: Clinical and Experimental, 56, 327-331.
13. Lee, J.W., Lee, H.R., Shim, J.Y., et al. (2008) Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects. Endocrine Journal, 55, 811-818.
14. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
15. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. (2001) Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA, 285, 2486-2497.
16. Saddichha, S., Manjunatha, N., Ameen, S., et al. (2008) Metabolic syndrome in first episode schizophrenia- a randomized double-blind controlled, short-term prospective study. Schizophrenia Research, 101, 266-272.
17. Cho, Y.M., Youn, B.S., Lee, H., et al. (2006) Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care, 29, 2457-2461. (Pubitemid 44912252)
18. Mallat, Z., Simon, T., Benessiano, J., et al. (2009) Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. Journal of Clinical Endocrinology and Metabolism, 94, 255-260.
19. Han, S.H., Chin, B.S., Lee, H.S., et al. (2009) Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy. Metabolism: Clinical and Experimental, 58, 1523-1529.
20. Schindler, K., Haider, D., Wolzt, M., et al. (2006) Impact of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects. European Journal of Clinical Investigation, 36, 640-646. (Pubitemid 44213831)
21. Broch, M., Gomez, J.M., Auguet, M.T., et al. (2010) Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women. Obesity Surgery, 20, 1258-1264.
22. Tschoner, A., Sturm, W., Engl, J., et al. (2008) Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity, 16, 2439-2444.
23. Ng, T.W., Watts, G.F., Barrett, P.H., et al. (2007) Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care, 30, 2945-2950. (Pubitemid 350083149)
24. Gomez-Ambrosi, J., Rodriguez, A., Catalan, V., et al. (2008) Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clinical Endocrinology, 69, 208-215. (Pubitemid 352009009)
25. Chiba, M., Saitoh, S., Ohnishi, H., et al. (2010) Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese-the Tanno and Sobetsu study. Endocrine Journal, 29, 811-817.
26. Choi, KM., Yannakoulia, M., Park, MS, et al. (2011) Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study. The American Journal of Clinical Nutrition, 93, 19-26.
27. Yildizhan, R., Ilhan, G.A., Yildizhan, B., et al. (2011) Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome. Fertility and Sterility, 96, 246-250.